Advertisement
ARBE vs BMI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARBE is a Buy and BMI is a Hold.
ARBE's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for ARBE turned positive on November 03, 2026. Looking at past instances where ARBE's MACD turned positive, the stock continued to rise in 38 of 45 cases over the following month. The odds of a continued upward trend are 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ARBE's RSI Oscillator exited the oversold zone, 33 of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on ARBE as a result. In 65 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.
Following a +14.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARBE advanced for three days, in 182 of 232 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
ARBE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARBE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for ARBE entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.365) is normal, around the industry mean (1.448). P/E Ratio (-1.276) is within average values for comparable stocks, (5.350). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.470). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (43.103) is also within normal values, averaging (32.028).
The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. ARBE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARBE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.
BMI saw its Stochastic Oscillator recovers from the overbought zone
The Stochastic Oscillator for BMI moved out of overbought territory on November 09, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 63 similar instances where the indicator exited the overbought zone. In 42 of the 63 cases the stock moved lower. This puts the odds of a downward move at 67%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for BMI moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 18 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 60%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
BMI broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on BMI as a result. In 60 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.
The Moving Average Convergence Divergence (MACD) for BMI just turned positive on October 09, 2026. Looking at past instances where BMI's MACD turned positive, the stock continued to rise in 28 of 46 cases over the following month. The odds of a continued upward trend are 61%.
BMI moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BMI crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 56%.
Following a +4.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMI advanced for three days, in 184 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
The Aroon Indicator entered an Uptrend today. In 110 of 211 cases where BMI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. BMI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 49 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 56 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 70 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock better than average.
The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.714) is normal, around the industry mean (1.448). P/E Ratio (36.786) is within average values for comparable stocks, (5.350). Projected Growth (PEG Ratio) (2.931) is also within normal values, averaging (5.470). Dividend Yield (0.011) settles around the average of (0.012) among similar stocks. P/S Ratio (4.255) is also within normal values, averaging (32.028).
BMI | ||
|---|---|---|
OUTLOOK RATING 1..100 | 22 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 82 Overvalued | |
PROFIT vs RISK RATING 1..100 | 70 | |
SMR RATING 1..100 | 49 | |
PRICE GROWTH RATING 1..100 | 39 | |
P/E GROWTH RATING 1..100 | 56 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ARBE | BMI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 82% | 2 days ago 60% |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 67% |
| Momentum ODDS (%) | 2 days ago 83% | 2 days ago 64% |
| MACD ODDS (%) | 2 days ago 84% | 2 days ago 61% |
| TrendWeek ODDS (%) | 2 days ago 78% | 2 days ago 62% |
| TrendMonth ODDS (%) | 2 days ago 88% | 2 days ago 62% |
| Advances ODDS (%) | 3 days ago 78% | 17 days ago 60% |
| Declines ODDS (%) | 7 days ago 89% | 6 days ago 58% |
| BollingerBands ODDS (%) | 2 days ago 81% | 2 days ago 52% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 52% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ARBE’s FA Score shows that 1 FA rating(s) are green while BMI’s FA Score has 0 green FA rating(s).
- ARBE’s FA Score: 1 green, 4 red.
- BMI’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ARBE’s TA Score shows that 5 TA indicator(s) are bullish while BMI’s TA Score has 6 bullish TA indicator(s).
- ARBE’s TA Score: 5 bullish, 3 bearish.
- BMI’s TA Score: 6 bullish, 4 bearish.
Price Growth
ARBE (@Electronic Equipment/Instruments) experienced а +9.82% price change this week, while BMI (@Electronic Equipment/Instruments) price change was +3.28% for the same time period.
The average weekly price growth across all stocks in the @Electronic Equipment/Instruments industry was -0.89%. For the same industry, the average monthly price growth was -11.03%, and the average quarterly price growth was -15.84%.
Reported Earning Dates
ARBE is expected to report earnings on Nov 19, 2026.
BMI is expected to report earnings on Jan 22, 2027.
Industries' Descriptions
@Electronic Equipment/Instruments (-0.89% weekly)This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.
Advertisement
ARBE and
Correlation & Price change
A.I.dvisor indicates that over the last year, ARBE has been loosely correlated with REKR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ARBE jumps, then REKR could also see price increases.
| Ticker / NAME | Correlation To ARBE | 1D Price Change % | ||
|---|---|---|---|---|
| ARBE | 100% | -0.64% | ||
| REKR - ARBE | 50% Loosely correlated | -7.95% | ||
| CRWD - ARBE | 41% Loosely correlated | -1.23% | ||
| AI - ARBE | 37% Loosely correlated | -1.33% | ||
| CRNC - ARBE | 36% Loosely correlated | -0.23% | ||
| MKSI - ARBE | 36% Loosely correlated | +0.89% | ||
More | ||||
BMI and
Correlation & Price change
A.I.dvisor indicates that over the last year, BMI has been loosely correlated with BKSY. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if BMI jumps, then BKSY could also see price increases.
| Ticker / NAME | Correlation To BMI | 1D Price Change % | ||
|---|---|---|---|---|
| BMI | 100% | -1.01% | ||
| BKSY - BMI | 33% Loosely correlated | -0.25% | ||
| ARBE - BMI | 28% Poorly correlated | -0.64% | ||
| NOVT - BMI | 27% Poorly correlated | -15.26% | ||
| VNT - BMI | 24% Poorly correlated | -1.71% | ||
| TRMB - BMI | 23% Poorly correlated | +0.13% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GEMG | 3.52 | N/A | N/A |
| Leverage Shares 2X Long GEMI Daily ETF (GEMG) | |||
| FTOH | 8.21 | -0.03 | -0.36% |
| Franklin Ohio Municipal Income ETF (FTOH) | |||
| QLTA | 45.69 | -0.29 | -0.63% |
| iShares Aaa-A Rated Corporate Bond ETF (QLTA) | |||
| QUSA | 15.97 | -0.12 | -0.75% |
| Vistashares Target 15 Usa Quality Income ETF | |||
| PTH | 59.35 | -0.57 | -0.95% |
| Invesco Dorsey Wright Healthcare Momentum ETF (PTH) | |||